Differential effects of 1,25-dihydroxyvitamin D on mineralisation anddifferentiation in two different types of osteoblast-like cultures

Journal of Steroid Biochemistry and Molecular Biology

Volumn 136, Issue 1, 2013, Pages 166-170

  Yang, D ^a,b,c   Atkins, G J ^c   Turner, A G ^b,d   Anderson, P H ^b,d   Morris, H A ^a,b,d  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b Endocrine Bone Research Laboratory   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

1,25 Dihydroxyvitamin D; Mineralisation; Osteoblast differentiation; Osteogenesis

Indexed keywords

BETA ACTIN; CALCITRIOL; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSCRIPTION FACTOR RUNX2; VITAMIN D RECEPTOR;

ABSORPTION; ANIMAL CELL; BONE DEVELOPMENT; BONE MINERALIZATION; CELL ASSAY; CELL CULTURE; CELL DIFFERENTIATION; CHEMICAL ANALYSIS; CONTROLLED STUDY; GENE EXPRESSION; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOBLAST; REAL TIME POLYMERASE CHAIN REACTION; REVIEW;

EID: 84881140922     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2012.11.016     Document Type: Review

References (15)

1. G.S. Stein, J.B. Lian, Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype, Endocrine Reviews 14 (4) (1993) 424-442.
2. V. Kartsogiannis, K.W. Ng, Cell lines and primary cell cultures in the study of bone cell biology, Molecular and Cellular Endocrinology 228 (1-2) (2004) 79-102.
3. G.J. Atkins, D.M. Findlay, P.H. Anderson, H.A. Morris, Target genes: bone proteins, in: D. Feldman, J.W. Pike, J.S. Adams (Eds.), Vitamin D, 3rd edition, Elsevier, San Diego, 2011.
4. T.A. Owen, et al., Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures, Endocrinology 128 (3) (1991) 1496-1504.
5. G.J. Atkins, et al., RANKL expression is related to the differentiation state of human osteoblasts, Journal of Bone and Mineral Research 18 (6) (2003) 1088-1098.
6. V.J. Woeckel, et al., 1Alpha,25-(OH)2D3 acts in the early phase of osteoblast differentiation to enhance mineralization via accelerated production of mature matrix vesicles, Journal of Cellular Physiology 225 (2) (2010) 593-600.
7. K. Sooy, Y. Sabbagh, M.B. Demay, Osteoblasts lacking the vitamin D receptor display enhanced osteogenic potential in vitro, Journal of Cellular Biochemistry 94 (1) (2005) 81-87.
8. D.K. Panda, et al., Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis, Journal of Biological Chemistry 279 (16) (2004) 16754-16766.
9. A. Bakker, J. Klein-Nulend, Osteoblast isolation from murine calvariae and long bones, Methods in Molecular Medicine 80 (2003) 19-28.
10. H. Zhou, et al., Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling, Journal of Biological Chemistry 283 (4) (2008) 1936-1945.
11. L.D. Quarles, et al., Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development, Journal of Bone and Mineral Research 7 (6) (1992) 683-692.
12. M. Morike, et al., Expression of osteoblastic markers in cultured human bone and fracture callus cells, Journal of Molecular Medicine (Berlin) 73 (11) (1995) 571-575.
13. R. Yamamoto, et al., 1alpha,25-dihydroxyvitamin D3 acts predominately in mature osteoblasts under conditions of high extracellular phosphate to increase fibroblast growth factor 23 production in vitro, Journal of Endocrinology 206 (3) (2010) 279-286.
14. W.N. Addison, et al., MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM, Journal of Bone and Mineral Research 23 (10) (2008)1638-1649.
15. G.J. Atkins, et al., Sclerostin is a locally acting regulator of lateosteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism, Journal of Bone and Mineral Research 26 (7) (2011) 1425-1436.